Imagine the following scenario. Your health system announced its intention to acquire and partner with local practitioners as part of its strategy to decrease the cost of care while delivering additional access points.
Tragic events can occur at any time, but avoidable ones somehow seem worse. In 2012, 64 people died and more than 700 people became ill due to a nationwide fungal meningitis outbreak. After an investigation, it was determined the cause of the outbreak was due to contaminated steroid injections prepared by a compounding pharmacy.
Supply aggregation groups, in various forms, have been around for many years. Now however, the constant push to lower costs combined with the movement toward value-based care, has increased interest from all types and sizes of hospitals.
Please enjoy our Winter Reading List, a compilation of our most popular newsletter stories and blogs about clinical and care delivery, research and insights and supply chain issues from 2021. We hope it helps spark inspiration for the new year.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.